
Sign up to save your podcasts
Or
In this episode, Duane Mancini welcomes to the show Aaron DeGagne, Healthcare Senior Analyst at PitchBook. From quarterly reports to market dynamics, Aaron sheds light on significant healthcare investments, including the rise in surgical tools, devices, and the blurring lines between healthtech and medtech. They delve into the impact of global market uncertainties, interest rates, and the noteworthy deals like Neuralink’s $600 million raise. The conversation also explores themes like consumer health advancements, cancer diagnostics, and the potential shifts in IPO activities.
Aaron DeGagne LinkedIn
PitchBook Website
Duane Mancini LinkedIn
Project Medtech Website
Project Medtech LinkedIn
5
2323 ratings
In this episode, Duane Mancini welcomes to the show Aaron DeGagne, Healthcare Senior Analyst at PitchBook. From quarterly reports to market dynamics, Aaron sheds light on significant healthcare investments, including the rise in surgical tools, devices, and the blurring lines between healthtech and medtech. They delve into the impact of global market uncertainties, interest rates, and the noteworthy deals like Neuralink’s $600 million raise. The conversation also explores themes like consumer health advancements, cancer diagnostics, and the potential shifts in IPO activities.
Aaron DeGagne LinkedIn
PitchBook Website
Duane Mancini LinkedIn
Project Medtech Website
Project Medtech LinkedIn
66 Listeners
48 Listeners
57 Listeners
92 Listeners
9,336 Listeners
56,020 Listeners
9,515 Listeners
20 Listeners
17 Listeners
9,249 Listeners
7 Listeners
7 Listeners